Mass Spectrometry

The Mass Spectrometry Facility houses cutting-edge mass spectrometry and proteomics technologies for the study of protein structure and function, and their relationship to human disease.

Based on a collaborative model

  • Consultation to researchers interested in or engaged in biomarker identification, including basic protein identification, fractionation and anMass spectrometry alysis
  • Proteomic analyses for discovery studies, using in-gel and gel-free technologies
  • Design and development of Mass spectrometry-based research diagnostics and/or ELISA assays.

Based on a fee-for-service model

  • A range of NATA certified assays for steroids, metanephrines, vitamins and drugs
  • Assay service for research groups.


Dr Andrew Stephens
Head, Ovarian Cancer Biomarker Laboratory
Hudson Institute
t:+61 3 8572 2686

Dr George Streitberg
Principal Scientist
Monash Health
t:+61 3 9594 2055